Core Laboratories N.V. (CLB) Expected to Announce Earnings of $0.50 Per Share
Wall Street analysts forecast that Core Laboratories N.V. (NYSE:CLB) will post earnings per share of $0.50 for the current quarter, Zacks reports. Two analysts have made estimates for Core Laboratories N.V.’s earnings, with the highest EPS estimate coming in at $0.51 and the lowest estimate coming in at $0.50. Core Laboratories N.V. posted earnings of $0.35 per share during the same quarter last year, which suggests a positive year over year growth rate of 42.9%. The firm is scheduled to report its next earnings report on Wednesday, July 19th.
According to Zacks, analysts expect that Core Laboratories N.V. will report full year earnings of $2.18 per share for the current year, with EPS estimates ranging from $2.00 to $2.40. For the next fiscal year, analysts forecast that the firm will post earnings of $3.35 per share, with EPS estimates ranging from $2.51 to $4.10. Zacks Investment Research’s EPS averages are an average based on a survey of research firms that that provide coverage for Core Laboratories N.V..
Core Laboratories N.V. (NYSE:CLB) last announced its quarterly earnings results on Wednesday, April 19th. The oil and gas company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.03. Core Laboratories N.V. had a net margin of 11.10% and a return on equity of 43.28%. The company had revenue of $157.81 million for the quarter, compared to analysts’ expectations of $150.44 million. During the same quarter in the previous year, the company earned $0.37 earnings per share. Core Laboratories N.V.’s quarterly revenue was up 2.7% on a year-over-year basis.
A number of equities research analysts recently weighed in on CLB shares. Loop Capital upgraded shares of Core Laboratories N.V. from a “hold” rating to a “buy” rating and lifted their price objective for the company from $125.00 to $130.00 in a report on Friday, April 21st. Zacks Investment Research lowered shares of Core Laboratories N.V. from a “hold” rating to a “sell” rating in a report on Tuesday, April 11th. Tudor Pickering started coverage on shares of Core Laboratories N.V. in a report on Thursday, March 23rd. They set a “hold” rating for the company. Scotiabank set a $133.00 price objective on shares of Core Laboratories N.V. and gave the company a “hold” rating in a report on Wednesday, March 22nd. Finally, Citigroup Inc. reiterated a “neutral” rating and set a $117.00 price objective (down previously from $119.00) on shares of Core Laboratories N.V. in a report on Saturday, March 11th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and four have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $121.22.
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Teachers Advisors LLC increased its position in shares of Core Laboratories N.V. by 24.1% in the first quarter. Teachers Advisors LLC now owns 887 shares of the oil and gas company’s stock worth $102,000 after buying an additional 172 shares during the last quarter. Parallel Advisors LLC increased its position in shares of Core Laboratories N.V. by 33.4% in the first quarter. Parallel Advisors LLC now owns 891 shares of the oil and gas company’s stock worth $101,000 after buying an additional 223 shares during the last quarter. Quantbot Technologies LP purchased a new position in shares of Core Laboratories N.V. during the first quarter worth about $106,000. Advisory Services Network LLC purchased a new position in shares of Core Laboratories N.V. during the first quarter worth about $118,000. Finally, FNY Managed Accounts LLC purchased a new position in shares of Core Laboratories N.V. during the first quarter worth about $123,000.
Shares of Core Laboratories N.V. (CLB) traded down 0.023% during trading on Monday, hitting $106.835. 137,336 shares of the company traded hands. The company has a 50 day moving average price of $106.39 and a 200 day moving average price of $113.82. Core Laboratories N.V. has a 52 week low of $96.30 and a 52 week high of $127.82. The company has a market capitalization of $4.72 billion, a price-to-earnings ratio of 70.752 and a beta of 1.51.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, May 23rd. Shareholders of record on Friday, April 28th were given a dividend of $0.55 per share. This represents a $2.20 dividend on an annualized basis and a yield of 2.06%. The ex-dividend date of this dividend was Thursday, April 27th. Core Laboratories N.V.’s dividend payout ratio (DPR) is 145.70%.
Core Laboratories N.V. Company Profile
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with MarketBeat.com's FREE daily email newsletter.